Vicarious Surgical Names Sarah Romano as CFO Amid Leadership Transition

Vicarious Surgical has appointed Sarah Romano as its new CFO, effective April 1, filling the role left vacant since January. Romano, formerly CFO at Entero Therapeutics, brings extensive experience in M&A and fundraising. Her arrival coincides with the retirement of Chief Operating Officer John Mazzola on the same day.

CEO Adam Sachs praised Romano’s financial expertise, calling her an "invaluable asset" as the company advances its single-port surgical robotics system. Vicarious recently projected a 2024 cash burn of $50M and is targeting hernia repair as its first clinical indication.